Clinical Study

SynapDx recently completed enrollment for the STORY study, one of the largest prospective, multi-site autism diagnostic studies. STORY included 880 children aged 18 months to fewer than 62 months at 20 developmental specialty centers in the US and Canada. The purpose of the study is to develop a blood test to assess a child’s risk of being diagnosed with an Autism Spectrum Disorder (ASD) when suspected of developmental delay. 

Participating sites are listed below:

 

Site Name

Site Investigator

Location

Baylor College of Medicine / Texas Children's Hospital

Robin Kochel PhD

Houston, TX

Children's Hospital Boston

William Barbaresi MD

Boston, MA

Children's Hospital of Philadelphia

Susan Levy MD

Philadelphia, PA

Cincinnati Children's Hospital Medical Center

Logan Wink MD

Cincinnati, OH

Emory University

Jeannie Visootsak MD

Decatur, GA

Glenrose Rehabilitation Hospital

Lonnie Zwaigenbaum MD

Keith Goulden MD

Edmonton, Alberta

Holland Bloorview Rehabilitation

Evdokia Anagnostou MD

Toronto, Ontario

Institute for Behavioral Research on Staten Island

Ted Brown MD

Staten Island, NY

Lurie Center Massachusetts General Hospital

Ann Neumeyer MD

Lexington, MA

Medical University of South Carolina

Michelle Macias MD

Charleston, SC

Melmed Center

Raun Melmed MD

Scottsdale, AZ

Miller Children's Hospital

Gary Feldman MD

Long Beach, CA

Mount Sinai School of Medicine / Seaver Center

Alex Kolevzon MD

New York, NY

Nationwide Children's Hospital

Dan Coury MD

Columbus, OH

Riley Hospital for Children

Tom Lock MD

Kimberly Stigler MD

Indianapolis, IN

Rush Medical Center

Cesar Ochoa-Lubinoff MD

Elizabeth Berry-Kravis MD

Chicago, IL

Seattle Children's Hospital

Charles Cowan MD

Seattle, WA

The MIND Institute, UC Davis

Robin Hansen MD

Kathleen Angkustsiri MD

Sacramento, CA

University of North Carolina - Chapel Hill

Linmarie Sikich MD

Chapel Hill, NC

Vanderbilt University

Zachary Warren PhD

Jeremy Veenstra-VanderWeele MD

Nashville, TN